Aptar Q2 sales top $1B; adjusted EPS $1.42; CEO Tanda to be succeeded by Touya on Sept 1

APTARGROUP, INC.

Reported sales $1.03B (+6% reported, +1% core); reported EPS $1.36, adjusted EPS $1.42 (vs $1.68 prior year).
Pharma core +1% (high single-digit ex-emergency medicine); Beauty core +1%; Closures core +4%.
Adjusted EBITDA margin 20.7% vs 22.6% prior year; margins impacted by product mix and operational factors.
Q3 adjusted EPS guidance $1.45-$1.53; dividend $0.48/share payable Aug 20; $50M share repurchases in Q2.
CEO Stephan Tanda to retire; Gael Touya to become CEO effective Sept 1, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.